| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 224.927 | 180.960 | 99.984 | 66.159 | 51.214 | 8.351 | 0 | 0 | 0 | - |
| Total Income - EUR | 226.473 | 182.900 | 102.154 | 66.935 | 53.682 | 7.439 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 171.557 | 114.284 | 80.853 | 65.407 | 35.911 | 20.778 | 0 | 0 | 0 | - |
| Gross Profit/Loss - EUR | 54.916 | 68.616 | 21.301 | 1.528 | 17.772 | -13.339 | 0 | 0 | 0 | - |
| Net Profit/Loss - EUR | 48.087 | 66.806 | 20.301 | 866 | 17.266 | -13.424 | 0 | 0 | 0 | - |
| Employees | 4 | 7 | 8 | 5 | 3 | 3 | 0 | 0 | 0 | - |
Check the financial reports for the company - Raw 3 Laboratories S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.558 | 13.107 | 7.713 | 2.494 | 118 | 0 | 0 | 0 | 0 | - |
| Current Assets | 44.467 | 107.675 | 57.700 | 68.470 | 113.915 | 98.442 | 96.259 | 96.185 | 95.893 | - |
| Inventories | 31.402 | 51.071 | 54.276 | 49.299 | 47.011 | 44.549 | 43.561 | 43.697 | 43.564 | - |
| Receivables | 3.325 | 49.222 | 825 | 19.111 | 66.825 | 53.892 | 52.696 | 52.487 | 52.328 | - |
| Cash | 9.740 | 7.382 | 2.599 | 60 | 79 | 1 | 1 | 1 | 1 | - |
| Shareholders Funds | 48.132 | 114.447 | 45.445 | 45.533 | 61.917 | 47.320 | 46.270 | 46.414 | 46.273 | - |
| Social Capital | 45 | 45 | 44 | 99 | 97 | 95 | 93 | 93 | 93 | - |
| Debts | 14.893 | 6.335 | 19.968 | 25.431 | 52.116 | 51.123 | 49.989 | 49.771 | 49.620 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4724 - 4724" | |||||||||
| CAEN Financial Year |
4724
|
|||||||||
Comments - Raw 3 Laboratories S.r.l.